Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Commercializing Protein Tomography Solutions

By Labmedica staff writers
Posted on 20 Mar 2006
Sidec Technologies (Torshmnagatan) and FEI company (Hillsboro) have announced that the two companies will collaborate on the commercialization of protein tomography solutions and software, using Sidec's software and intellectual property and FEI's transmission electron microscopes (TEMs). More...
Based on current practices, protein tomography is estimated to be a U.S.$200 million market with the potential to grow several-fold within a few years.

Protein tomography was developed for studying the molecular nature of disease pathways and for validating preclinical models and investigating the activity of candidate therapeutics. Protein tomography makes it possible to visualize biomolecules in situ, even in a cell membrane. FEI has developed cryo-electron microscopy for the imaging of biologic structures in collaboration with academic groups in Europe and the United States. Sidec is developing protein imaging using cryo-electron microscopy, and has research collaborations with global pharmaceutical companies.

Advanced electron microscopy instrumentation, data acquisition, and reconstruction software that enable the imaging and analysis of individual protein molecules in cells and tissues are being offered by FEI and Sidec. The service is being provided through Sidec, as an on-premises service or through software and other intellectual property license arrangements, combined with a TEM sale.


Related Links:
Sidec
FEI

New
Gold Member
Genetic Type 1 Diabetes Risk Test
T1D GRS Array
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.